IRWD IRONWOOD PHARMACEUTICALS INC
Nasdaq · SEC CIK 1446847 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $22.50M 11 sales by 8 insiders
- Filings on record
- 207 since 2021-07-22, latest 2026-09-17 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| DENNER ALEXANDER J | Dir, 10% | — | $20.53M |
| Silver Ronald | Principal Accounting Off | — | $831.2K |
| MCCOURT Thomas A | CEO, Dir | — | $739.9K |
| John Minardo | CLO | — | $136.2K |
| Gaskins Tammi L | Chief Commercial Off | — | $100.3K |
| Martini Gregory S. | CFO | — | $81.9K |
| McHugh Julie | Dir | — | $80.5K |
| Silber Jeffrey | SVP, CMO, Head-Res, Drug | — | — |
| Moukheibir Catherine | Dir | — | — |
| Duane Jon R | Dir | — | — |
Transactions 219
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-12 | 2024-02-08 | IRWD | Emany Sravan Kumar | SVP, CFO | F - Tax | $14.90 | -41.3K | 225.7K | -15% | -$615.8K | |
| 2024-01-19 | 2024-01-17 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +249.6K | 1.01M | +33% | $0 | |
| 2024-01-19 | 2024-01-17 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +58.0K | 379.1K | +18% | $0 | |
| 2024-01-19 | 2024-01-17 | IRWD | Emany Sravan Kumar | SVP, CFO | A - Grant | $0.00 | +85.0K | 267.1K | +47% | $0 | |
| 2024-01-19 | 2024-01-17 | IRWD | John Minardo | CLO | A - Grant | $0.00 | +80.0K | 272.2K | +42% | $0 | |
| 2023-12-19 | 2023-12-15 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +1,572 | 128.6K | +1% | $0 | |
| 2023-12-19 | 2023-12-15 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +1,347 | 120.3K | +1% | $0 | |
| 2023-12-18 | 2023-12-14 | IRWD | Kessler Marla L | Dir | S - Sale | $11.19 | -9,926 | 96.6K | -9% | -$111.1K | |
| 2023-11-22 | 2023-11-20 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $9.69 | -3,287 | 217.4K | -1% | -$31.9K | |
| 2023-11-20 | 2023-11-16 | IRWD | Emany Sravan Kumar | SVP, CFO | F - Tax | $9.44 | -6,661 | 182.1K | -4% | -$62.9K | |
| 2023-09-19 | 2023-09-15 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +2,098 | 127.1K | +2% | $0 | |
| 2023-09-19 | 2023-09-15 | IRWD | DENNER ALEXANDER J | Dir, 10% | A - Grant | $0.00 | +1,798 | 118.9K | +2% | $0 | |
| 2023-09-18 | 2023-09-15 | IRWD | Emany Sravan Kumar | SVP, CFO | P - Purchase | $8.32 | +36.1K | 188.7K | +24% | +$300.1K | |
| 2023-08-31 | 2023-08-29 | IRWD | Silver Ronald | Principal Accounting Off | A - Grant | $0.00 | +8,000 | 142.2K | +6% | $0 | |
| 2023-08-16 | 2023-08-14 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $10.04 | -1,976 | 134.2K | -1% | -$19.8K | |
| 2023-08-16 | 2023-08-14 | IRWD | John Minardo | CLO | S - Sale | $10.04 | -7,045 | 192.2K | -4% | -$70.7K | |
| 2023-06-22 | 2023-06-20 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +22.4K | 117.1K | +24% | $0 | |
| 2023-06-22 | 2023-06-20 | IRWD | Duane Jon R | Dir | A - Grant | $0.00 | +22.4K | 114.1K | +24% | $0 | |
| 2023-06-22 | 2023-06-20 | IRWD | Shepard Jay | Dir | A - Grant | $0.00 | +22.4K | 102.2K | +28% | $0 | |
| 2023-06-22 | 2023-06-20 | IRWD | McHugh Julie | Dir | A - Grant | $0.00 | +22.4K | 162.3K | +16% | $0 | |
| 2023-06-22 | 2023-06-20 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +22.4K | 125.0K | +22% | $0 | |
| 2023-06-22 | 2023-06-20 | IRWD | Currie Mark G | Dir | A - Grant | $0.00 | +22.4K | 544.1K | +4% | $0 | |
| 2023-06-22 | 2023-06-20 | IRWD | Dreyfus Andrew | Dir | A - Grant | $0.00 | +22.4K | 169.0K | +15% | $0 | |
| 2023-06-22 | 2023-06-20 | IRWD | Kessler Marla L | Dir | A - Grant | $0.00 | +22.4K | 106.5K | +27% | $0 | |
| 2023-06-20 | 2023-06-15 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +1,586 | 102.6K | +2% | $0 | |
| 2023-06-20 | 2023-06-15 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +1,359 | 94.8K | +1% | $0 | |
| 2023-06-01 | 2023-05-30 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $10.70 | -26.6K | 758.3K | -3% | -$285.0K | |
| 2023-05-24 | 2023-05-22 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $10.12 | -36.0K | 784.9K | -4% | -$364.3K | |
| 2023-05-24 | 2023-05-22 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $10.12 | -10.3K | 321.1K | -3% | -$104.5K | |
| 2023-05-24 | 2023-05-22 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $10.12 | -6,305 | 219.3K | -3% | -$63.8K | |
| 2023-05-10 | 2023-05-08 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $10.62 | -21.1K | 820.9K | -3% | -$224.6K | |
| 2023-03-29 | 2023-03-27 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $10.67 | -46.1K | 842.1K | -5% | -$492.2K | |
| 2023-03-17 | 2023-03-15 | IRWD | DENNER ALEXANDER J | Dir, 10% | A - Grant | $0.00 | +1,438 | 93.4K | +2% | $0 | |
| 2023-03-17 | 2023-03-15 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +1,677 | 101.0K | +2% | $0 | |
| D | 2023-03-10 | 2023-03-08 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +240.6K | 888.2K | +37% | $0 |
| 2023-03-10 | 2023-03-08 | IRWD | Silver Ronald | Principal Accounting Off | A - Grant | $0.00 | +35.6K | 134.1K | +36% | $0 | |
| D | 2023-03-10 | 2023-03-08 | IRWD | John Minardo | CLO | A - Grant | $0.00 | +65.5K | 199.2K | +49% | $0 |
| D | 2023-03-10 | 2023-03-08 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +69.9K | 331.5K | +27% | $0 |
| D | 2023-03-10 | 2023-03-08 | IRWD | Davis Andrew | SVP, Chief Business Off | A - Grant | $0.00 | +74.2K | 225.6K | +49% | $0 |
| D | 2023-03-10 | 2023-03-08 | IRWD | Emany Sravan Kumar | SVP, CFO | A - Grant | $0.00 | +74.2K | 152.7K | +95% | $0 |
| D | 2023-03-10 | 2023-03-08 | IRWD | Rickard Jason | SVP, COO | A - Grant | $0.00 | +43.7K | 376.3K | +13% | $0 |
| 2023-03-07 | 2023-03-03 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $11.22 | -33.8K | 647.6K | -5% | -$378.7K | |
| M | 2023-03-01 | 2023-02-27+ | IRWD | John Minardo | CLO | S - Sale | $11.36 | -6,697 | 137.2K | -5% | -$76.1K |
| M | 2023-03-01 | 2023-02-27+ | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $11.36 | -19.3K | 271.4K | -7% | -$219.5K |
| M | 2023-03-01 | 2023-02-27+ | IRWD | Rickard Jason | SVP, COO | S - Sale | $11.36 | -34.2K | 350.1K | -9% | -$388.2K |
| M | 2023-03-01 | 2023-02-27+ | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $11.36 | -61.2K | 681.4K | -8% | -$695.5K |
| M | 2023-03-01 | 2023-02-27+ | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $11.36 | -3,573 | 151.4K | -2% | -$40.6K |
| M | 2023-03-01 | 2023-02-27+ | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $11.36 | -5,978 | 101.5K | -6% | -$67.9K |
| 2023-01-19 | 2023-01-17 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +30.1K | 742.6K | +4% | $0 | |
| 2023-01-19 | 2023-01-17 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +14.7K | 280.9K | +6% | $0 | |
| 2023-01-19 | 2023-01-17 | IRWD | Rickard Jason | SVP, COO | A - Grant | $0.00 | +18.1K | 366.8K | +5% | $0 | |
| D | 2023-01-09 | 2023-01-05 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale+OE | $12.07 | -111.0K | 712.4K | -13% | -$1.34M |
| D | 2023-01-09 | 2023-01-05 | IRWD | MCCOURT Thomas A | CEO, Dir | M - OptEx | $11.65 | +111.0K | 823.4K | +16% | +$1.29M |
| 2022-12-19 | 2022-12-15 | IRWD | DENNER ALEXANDER J | Dir, 10% | A - Grant | $0.00 | +1,244 | 92.0K | +1% | $0 | |
| 2022-12-16 | 2022-12-14 | IRWD | Rickard Jason | SVP, COO | S - Sale | $12.39 | -27.0K | 348.7K | -7% | -$334.5K | |
| 2022-11-23 | 2022-11-21 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $11.56 | -3,335 | 154.2K | -2% | -$38.6K | |
| 2022-11-23 | 2022-11-21 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $11.56 | -682 | 104.5K | -0.6% | -$7,884 | |
| 2022-11-23 | 2022-11-21 | IRWD | Emany Sravan Kumar | SVP, CFO | S - Sale | $11.56 | -6,578 | 78.4K | -8% | -$76.0K | |
| 2022-10-05 | 2022-10-03 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $10.41 | -18.9K | 712.4K | -3% | -$196.7K | |
| 2022-09-19 | 2022-09-15 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +1,374 | 90.7K | +2% | $0 | |
| 2022-09-06 | 2022-09-01 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $10.65 | -26.4K | 731.3K | -3% | -$281.6K | |
| 2022-08-17 | 2022-08-15 | IRWD | John Minardo | CLO | S - Sale | $11.77 | -7,330 | 140.4K | -5% | -$86.3K | |
| 2022-08-17 | 2022-08-15 | IRWD | Rickard Jason | SVP, COO | S - Sale | $11.77 | -994 | 375.7K | -0.3% | -$11.7K | |
| 2022-08-17 | 2022-08-15 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $11.77 | -2,014 | 105.2K | -2% | -$23.7K | |
| 2022-08-15 | 2022-08-11 | IRWD | Currie Mark G | Dir | S - Sale | $11.78 | -70.0K | 521.8K | -12% | -$824.6K | |
| DM | 2022-08-10 | 2022-08-08+ | IRWD | Rickard Jason | SVP, COO | S - Sale+OE | $11.68 | -47.5K | 379.0K | -11% | -$554.4K |
| D | 2022-08-10 | 2022-08-09 | IRWD | Rickard Jason | SVP, COO | M - OptEx | $11.65 | +18.0K | 394.8K | +5% | +$210.2K |
| 2022-08-03 | 2022-08-01 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $11.35 | -23.2K | 757.8K | -3% | -$263.6K | |
| 2022-07-05 | 2022-06-30 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $11.58 | -20.0K | 778.9K | -2% | -$231.1K | |
| 2022-06-17 | 2022-06-15 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +1,222 | 89.4K | +1% | $0 | |
| 2022-06-16 | 2022-06-14 | IRWD | Kessler Marla L | Dir | S - Sale | $11.65 | -7,610 | 84.1K | -8% | -$88.7K | |
| D | 2022-06-09 | 2022-06-07 | IRWD | Currie Mark G | Dir | M - OptEx | $11.65 | +190.4K | 782.1K | +32% | +$2.22M |
| D | 2022-06-09 | 2022-06-07 | IRWD | Currie Mark G | Dir | S - Sale+OE | $12.01 | -190.4K | 591.8K | -24% | -$2.29M |
| 2022-06-03 | 2022-06-01 | IRWD | Currie Mark G | Dir | A - Grant | $0.00 | +21.6K | 591.8K | +4% | $0 | |
| 2022-06-03 | 2022-06-01 | IRWD | Dreyfus Andrew | Dir | A - Grant | $0.00 | +21.6K | 151.6K | +17% | $0 | |
| 2022-06-03 | 2022-06-01 | IRWD | Duane Jon R | Dir | A - Grant | $0.00 | +21.6K | 91.8K | +31% | $0 | |
| 2022-06-03 | 2022-06-01 | IRWD | McHugh Julie | Dir | A - Grant | $0.00 | +21.6K | 139.9K | +18% | $0 | |
| 2022-06-03 | 2022-06-01 | IRWD | Kessler Marla L | Dir | A - Grant | $0.00 | +21.6K | 91.8K | +31% | $0 | |
| 2022-06-03 | 2022-06-01 | IRWD | Shepard Jay | Dir | A - Grant | $0.00 | +21.6K | 79.9K | +37% | $0 | |
| 2022-06-03 | 2022-06-01 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +21.6K | 99.3K | +28% | $0 | |
| 2022-06-03 | 2022-06-01 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +21.6K | 88.1K | +32% | $0 | |
| 2022-05-25 | 2022-05-23 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $11.50 | -120 | 105.1K | -0.1% | -$1,380 | |
| M | 2022-05-25 | 2022-05-23 | IRWD | Rickard Jason | SVP, COO | S - Sale | $11.50 | -13.5K | 404.1K | -3% | -$155.7K |
| M | 2022-05-25 | 2022-05-23 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $11.50 | -10.6K | 266.2K | -4% | -$121.7K |
| M | 2022-05-25 | 2022-05-23 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $11.50 | -36.3K | 832.6K | -4% | -$417.5K |
| 2022-03-25 | 2022-03-24 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $12.75 | -3,031 | 105.2K | -3% | -$38.6K | |
| 2022-03-17 | 2022-03-15 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +1,466 | 77.8K | +2% | $0 | |
| 2022-03-17 | 2022-03-15 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +1,152 | 66.6K | +2% | $0 | |
| 2022-03-16 | 2022-03-14 | IRWD | McHugh Julie | Dir | S - Sale | $11.67 | -20.0K | 118.4K | -14% | -$233.4K | |
| 2022-03-10 | 2022-03-08 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +248.9K | 835.2K | +42% | $0 | |
| 2022-03-04 | 2022-03-02 | IRWD | John Minardo | CLO | A - Grant | $0.00 | +67.9K | 147.8K | +85% | $0 | |
| M | 2022-03-04 | 2022-03-02 | IRWD | Silver Ronald | Principal Accounting Off | A - Grant | $0.00 | +47.0K | 108.2K | +77% | $0 |
| 2022-03-04 | 2022-03-02 | IRWD | Rickard Jason | SVP, COO | A - Grant | $0.00 | +90.5K | 417.6K | +28% | $0 | |
| 2022-03-04 | 2022-03-02 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +81.4K | 276.8K | +42% | $0 | |
| M | 2022-03-02 | 2022-02-28 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $10.77 | -48.4K | 586.3K | -8% | -$521.5K |
| M | 2022-03-02 | 2022-02-28 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $10.77 | -17.6K | 211.6K | -8% | -$189.6K |
| M | 2022-03-02 | 2022-02-28 | IRWD | Rickard Jason | SVP, COO | S - Sale | $10.77 | -29.0K | 354.2K | -8% | -$311.9K |
| M | 2022-03-02 | 2022-02-28 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $10.77 | -2,238 | 63.0K | -3% | -$24.1K |
| 2022-01-21 | 2022-01-19 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +60.3K | 634.7K | +10% | $0 | |
| 2022-01-21 | 2022-01-19 | IRWD | Rickard Jason | SVP, COO | A - Grant | $0.00 | +36.2K | 356.1K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations